Hangzhou Youngpeptide Biotechnology HYB
Retatrutide
Finnrick tested 2 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Hangzhou Youngpeptide Biotechnology HYB between 5 Aug 2025 and 10 Dec 2025. Test scores average below 4 or some scores below 3, and at least 2 tests, warrant a tentative Finnrick Rating of E (Bad).
Finnrick Rating™
Tentative Rating
Hangzhou Youngpeptide Biotechnology HYB
Retatrutide
Tested 2 Samples
Last test 10 Dec 2025
Take Action
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from Hangzhou Youngpeptide Biotechnology HYB
Samples are tested in commercial labs
Tests Count
2
Scores
AVGMINMAX
Last
10 Dec 2025
First
5 Aug 2025
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 10 Dec 2025 | View | 10mg | ⚠️ Sample does not contain Retatrutide | (no batch ID) | No Label / Silver Crimp / Blue Cap | Lab G | Public | |||
| 5 Aug 2025 | View | 5mg | 5.51mg | +10.2% | 99.20% | (no batch ID) | Clear Label / Silver Crimp / Grey Cap | Lab D | Public | |